Literature DB >> 28892912

Important Diagnostic Clues for Diagnosing Splenic Marginal Zone Lymphoma in Absence of Splenic Histology.

Anisha Mohanpuria1, Vijay Kumar2, Pooja Suteri3, Sadhna Marwah4, Abhay Shankar Nigam5.   

Abstract

Splenic Marginal Zone Lymphoma (SMZL) is a rare B-cell neoplasm comprising less than 2% of non-Hodgkin lymphomas. We hereby report a case of SMZL in a 66-year-old female who presented with fever and massive splenomegaly. Peripheral blood smear examination showed atypical lymphoid cells showing variable cytoplasmic processes. Flowcytometric immunophenotyping of peripheral blood showed tumour cells which were found to be positive for CD19, CD79b and showing kappa light chain restriction along with lack of expression for CD5, CD10, CD23, CD103 and lambda. These findings were suggestive of B cell chronic lymphoproliferative disorder. Various differential diagnoses considered in this case were analysed by using different diagnostic clues to arrive at the diagnosis. Bone marrow examination and Immunohistochemical (IHC) analysis showed tumour cells in nodular, interstitial and intrasinusoidal pattern of infiltration which were positive for CD20 and CD79b with kappa light chain restriction and lack of expression of CD5, CD10, CD23 and CD103 which further corroborated the flowcytometric immunophenotyping. The diagnosis of SMZL is arrived at by a combination of diagnostic clues like clinical features, peripheral smear findings, flowcytometric immunophenotyping, morphological and IHC findings in bone marrow biopsy. This case highlights the significance of flowcytometric immunophenotyping and bone marrow biopsy with immunohistochemistry to arrive at a diagnosis of SMZL even in absence of splenic histopathology.

Entities:  

Keywords:  CD20; Intrasinusoidal pattern; Massive splenomegaly

Year:  2017        PMID: 28892912      PMCID: PMC5583942          DOI: 10.7860/JCDR/2017/27149.10190

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  6 in total

Review 1.  Genetic abnormalities in marginal zone B-cell lymphoma.

Authors:  J Dierlamm; I Wlodarska; L Michaux; M Stefanova; K Hinz; H Van Den Berghe; A Hagemeijer; D K Hossfeld
Journal:  Hematol Oncol       Date:  2000-03       Impact factor: 5.271

Review 2.  Splenic marginal zone lymphoma.

Authors:  Vito Franco; Ada Maria Florena; Emilio Iannitto
Journal:  Blood       Date:  2002-11-21       Impact factor: 22.113

Review 3.  Diagnosis of splenic B-cell lymphomas in the bone marrow: a review of histopathologic, immunophenotypic, and genetic findings.

Authors:  Amir Behdad; Nathanael G Bailey
Journal:  Arch Pathol Lab Med       Date:  2014-10       Impact factor: 5.534

Review 4.  Splenic marginal zone lymphoma: from genetics to management.

Authors:  Luca Arcaini; Davide Rossi; Marco Paulli
Journal:  Blood       Date:  2016-03-17       Impact factor: 22.113

5.  Prognostic features of splenic lymphoma with villous lymphocytes: a report on 129 patients.

Authors:  Nilima Parry-Jones; Estella Matutes; Alicja M Gruszka-Westwood; G John Swansbury; Andrew C Wotherspoon; Daniel Catovsky
Journal:  Br J Haematol       Date:  2003-03       Impact factor: 6.998

6.  Primary non-Hodgkin lymphoma of the spleen.

Authors:  A Brox; J I Bishinsky; G Berry
Journal:  Am J Hematol       Date:  1991-10       Impact factor: 10.047

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.